Malcolm Fairbairn's most recent trade in Tff Pharmaceuticals Inc was a trade of 10,000 Common Stock done at an average price of $9.0 . Disclosure was reported to the exchange on May 19, 2021.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Tff Pharmaceuticals Inc | Malcolm Fairbairn | Director | Purchase of securities on an exchange or from another person at price $ 8.95 per share. | 19 May 2021 | 10,000 | 10,000 (0%) | 0% | 9.0 | 89,500 | Common Stock |
Tff Pharmaceuticals Inc | Malcolm Fairbairn | Director | Sale of securities on an exchange or to another person at price $ 15.93 per share. | 11 Nov 2020 | 63,331 | 11,669 (0%) | 0% | 15.9 | 1,008,926 | Common Stock |
Tff Pharmaceuticals Inc | Malcolm Fairbairn | Director | Sale of securities on an exchange or to another person at price $ 15.97 per share. | 11 Nov 2020 | 11,669 | 0 (0%) | 0% | 16.0 | 186,307 | Common Stock |
Tff Pharmaceuticals Inc | Malcolm Fairbairn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Aug 2020 | 13,200 | 105,455 | - | - | Stock Options (Right to Buy) |